Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler in Subjects With Asthma
Status:
Completed
Trial end date:
2018-09-30
Target enrollment:
Participant gender:
Summary
Male and female subjects with mild to moderate asthma will be recruited to enroll in a 2-way
crossover during which escalating doses of albuterol will be administered at 30 minute
intervals on a single treatment day. Albuterol will be administered by the Halix albuterol
unit dose disposable inhaler on one day and by Ventolin albuterol HFA MDI on the other day.
Assignment to device for albuterol delivery will be by random allocation.